Hormonal Contraception and Risk of Chlamydia and Gonorrhea

This study has been terminated.
Information provided by National Institute of Child Health and Human Development (NICHD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Chlamydia Infection
			Neisseriaceae Infection
2		Additional conditions recognized in this trial
			Chlamydia Infections
			Communicable Diseases
			Infection
			Neisseriaceae Infections
3		More general conditions related to this trial
			Bacterial Infections
			Chlamydiaceae Infections
			Genital Diseases, Female
			Genital Diseases, Male
			Gram-Negative Bacterial Infections
			Sexually Transmitted Diseases
			Sexually Transmitted Diseases, Bacterial
4		Interventions listed in this trial
			Depo Medroxyprogesterone acetate
			Combined oral contraceptives
5		Additional drug interventions recognized in this trial
			Medroxyprogesterone
			Medroxyprogesterone 17-Acetate
6		More general drug interventions related to this trial
			Antineoplastic Agents
			Antineoplastic Agents, Hormonal
			Contraceptive Agents
			Contraceptive Agents, Female
			Contraceptive Agents, Male
			Contraceptives, Oral
			Contraceptives, Oral, Synthetic
			Pharmacologic Actions
			Physiological Effects of Drugs
			Reproductive Control Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Child Health and Human Development (NICHD)